NeOnc Current Deferred Revenue from 2010 to 2025

NTHI Stock   8.57  0.22  2.63%   
NeOnc Technologies' Current Deferred Revenue is decreasing with slightly volatile movements from year to year. Current Deferred Revenue is predicted to flatten to about 400 K. Current Deferred Revenue is revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends. View All Fundamentals
 
Current Deferred Revenue  
First Reported
2010-12-31
Previous Quarter
450 K
Current Value
400 K
Quarterly Volatility
27.2 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check NeOnc Technologies financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among NeOnc Technologies' main balance sheet or income statement drivers, such as Interest Expense of 1.6 M, Selling General Administrative of 3.1 M or Total Revenue of 47.7 K, as well as many indicators such as . NeOnc financial statements analysis is a perfect complement when working with NeOnc Technologies Valuation or Volatility modules.
  
Build AI portfolio with NeOnc Stock
Check out the analysis of NeOnc Technologies Correlation against competitors.

Currently Active Assets on Macroaxis

When determining whether NeOnc Technologies offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of NeOnc Technologies' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Neonc Technologies Holdings, Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Neonc Technologies Holdings, Stock:
Check out the analysis of NeOnc Technologies Correlation against competitors.
You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of NeOnc Technologies. If investors know NeOnc will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about NeOnc Technologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.47)
Revenue Per Share
0.005
Quarterly Revenue Growth
(0.07)
The market value of NeOnc Technologies is measured differently than its book value, which is the value of NeOnc that is recorded on the company's balance sheet. Investors also form their own opinion of NeOnc Technologies' value that differs from its market value or its book value, called intrinsic value, which is NeOnc Technologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because NeOnc Technologies' market value can be influenced by many factors that don't directly affect NeOnc Technologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between NeOnc Technologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if NeOnc Technologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, NeOnc Technologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.